Molly White
Corporate Officer/Principal chez DYNE THERAPEUTICS, INC.
Profil
Molly White is currently the Vice President-Strategic Initiatives at Dyne Therapeutics, Inc. She previously served as the Chief Executive Officer at Myotonic Dystrophy Foundation from 2012 to 2019.
Ms. White holds a graduate degree from the University of Iowa and an undergraduate degree from The University of Montana.
Postes actifs de Molly White
| Sociétés | Poste | Début |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2020 |
Anciens postes connus de Molly White
| Sociétés | Poste | Fin |
|---|---|---|
Myotonic Dystrophy Foundation
 Myotonic Dystrophy Foundation Investment Trusts/Mutual FundsMiscellaneous The Myotonic Dystrophy Foundation is a non-profit organization that supports families living with myotonic dystrophy by providing comprehensive resources and driving research to accelerate the discovery of therapies. The non-profit company is based in San Francisco, CA. The foundation has invested over $10,000,000 and has served more than 10,000 people. The company's mission is to support and connect the myotonic dystrophy community, provide resources and advocate for care, and accelerate research toward treatments and a cure. | Directeur des opérations | 01/12/2019 |
Formation de Molly White
| University of Iowa | Graduate Degree |
| The University of Montana | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Myotonic Dystrophy Foundation
Myotonic Dystrophy Foundation Investment Trusts/Mutual FundsMiscellaneous The Myotonic Dystrophy Foundation is a non-profit organization that supports families living with myotonic dystrophy by providing comprehensive resources and driving research to accelerate the discovery of therapies. The non-profit company is based in San Francisco, CA. The foundation has invested over $10,000,000 and has served more than 10,000 people. The company's mission is to support and connect the myotonic dystrophy community, provide resources and advocate for care, and accelerate research toward treatments and a cure. | Miscellaneous |
